Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. (Q40130425)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

6

Louise M Burrell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Rebecca A Lew

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Fiona J Warner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Iresha Hanchapola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Michael A Yarski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

A Ian Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

25 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Experimental Physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

685-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18223027%20AND%20SRC:MED&resulttype=core&format=json

High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

ADAMs: key components in EGFR signalling and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Myocardial infarction increases ACE2 expression in rat and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Canine pulmonary angiotensin-converting enzyme. Physicochemical, catalytic and immunological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

A Sensitive Fluorimetric Assay for Serum Angiotensin-con venrting Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Angiotensin converting enzyme: Implications from molecular biology for its physiological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Characterisation of endothelin converting enzyme-1 shedding from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Conversion of angiotensin I to angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Secretase-mediated cell surface shedding of the angiotensin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

The existence of two forms of hypertensin

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Inhibitors of metalloendopeptidase EC 3.4.24.15 and EC 3.4.24.16 stabilized against proteolysis by the incorporation of beta-amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

The use of knockout mouse technology to achieve tissue selective expression of angiotensin converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.040352

An improved fluorometric assay of rat serum and plasma converting enzyme

21 January 2018

1 reference

12 December 2020

Measurement of human converting enzyme level by direct radioimmunoassay

1 reference

12 December 2020

Characterization of Angiotensin Converting Enzyme-2 (ACE2) in Human Urine

1 reference

12 December 2020

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis

1 reference

12 December 2020

Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II

1 reference

12 December 2020

Renal ACE2 expression in human kidney disease

1 reference

12 December 2020